Clinical features of primary sclerosing cholangitis with onset age above 50 years
- PMID: 18807135
- DOI: 10.1007/s00535-008-2216-3
Clinical features of primary sclerosing cholangitis with onset age above 50 years
Abstract
Background: Although there are two peaks in the age distribution of primary sclerosing cholangitis (PSC) in Japan, the clinical differences between the patients with an older or younger onset age have not been reported.
Methods: We compared clinical features of 18 patients with onset age less than 50 years (younger group) and ten PSC patients with onset age above 50 years (older group).
Results: An association with ulcerative colitis (UC) was recognized in six patients in the younger group and in one in the older group. High serum IgE (>170 IU/ml) was observed more frequently in the older than in the younger group (1/10 vs. 7/8, P = 0.0029). Mean serum IgM tended to be higher in the younger group (198 vs. 119 mg/dl, P = 0.083). More patients received liver transplantation or continuous bile drainage, or developed liver failure or cholangiocellular carcinoma in the younger than in the older group (11/18 vs. 1/10, P = 0.016).
Conclusions: Older PSC patients have higher IgE, possibly less association with UC, lower IgM, and a better prognosis. The pathogenesis of PSC may be different between older and younger patients.
Similar articles
-
Lower incidence of biliary carcinoma in patients with primary sclerosing cholangitis and high serum levels of immunoglobulin E.Clin Gastroenterol Hepatol. 2012 Jan;10(1):79-83. doi: 10.1016/j.cgh.2011.09.015. Epub 2011 Oct 1. Clin Gastroenterol Hepatol. 2012. PMID: 21963955
-
The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.Aliment Pharmacol Ther. 2012 May;35(9):1045-53. doi: 10.1111/j.1365-2036.2012.05063.x. Epub 2012 Mar 19. Aliment Pharmacol Ther. 2012. PMID: 22428605
-
Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients.PLoS One. 2018 Dec 20;13(12):e0209352. doi: 10.1371/journal.pone.0209352. eCollection 2018. PLoS One. 2018. PMID: 30571774 Free PMC article.
-
Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease.Acta Med Okayama. 1996 Oct;50(5):227-35. doi: 10.18926/AMO/30499. Acta Med Okayama. 1996. PMID: 8914675 Review.
-
Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.Semin Liver Dis. 2006 Feb;26(1):31-41. doi: 10.1055/s-2006-933561. Semin Liver Dis. 2006. PMID: 16496231 Review.
Cited by
-
Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis.United European Gastroenterol J. 2018 Mar;6(2):255-262. doi: 10.1177/2050640617717156. Epub 2017 Jun 17. United European Gastroenterol J. 2018. PMID: 29511555 Free PMC article.
-
Clinical guidelines for primary sclerosing cholangitis 2017.J Gastroenterol. 2018 Sep;53(9):1006-1034. doi: 10.1007/s00535-018-1484-9. Epub 2018 Jun 27. J Gastroenterol. 2018. PMID: 29951926 Free PMC article.
-
Leveraging a New ICD-10 Diagnosis Code to Characterize Hospitalized Patients With Primary Sclerosing Cholangitis.Clin Gastroenterol Hepatol. 2023 Sep;21(10):2692-2694. doi: 10.1016/j.cgh.2022.09.001. Epub 2022 Sep 14. Clin Gastroenterol Hepatol. 2023. PMID: 36113826 Free PMC article. No abstract available.
-
Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study.Int J Mol Sci. 2023 Oct 21;24(20):15431. doi: 10.3390/ijms242015431. Int J Mol Sci. 2023. PMID: 37895106 Free PMC article.
-
Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan.Hepatol Int. 2023 Oct;17(5):1215-1224. doi: 10.1007/s12072-023-10557-2. Epub 2023 Jul 26. Hepatol Int. 2023. PMID: 37493884 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources